课题基金 / 基金详情

Efficacy and mechanisms of exercise training in diastolic heart failure

Efficacy and mechanisms of exercise training in diastolic heart failure
运动训练治疗舒张性心力衰竭的疗效及机制
批准号:
nhmrc : 301136
负责人:
A/Pr David Prior
金额:
$25.69万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2004
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2004-01-01 至 2005-12-31

项目摘要

项目成果

A/Pr David Prior的其他基金

相似基金

相关文献

中文摘要
翻译
心力衰竭是一种现代流行病,由于死亡率高、频繁住院和功能能力受损,造成了重大的公共卫生负担。虽然典型的心力衰竭患者表现为收缩功能降低,但许多患者具有典型的心力衰竭症状,但收缩正常。这些患者的问题似乎与心脏的血液充盈能力有关,这种实体被称为舒张性心力衰竭(DHF)。这种综合征最常见于缺血性或高血压性心脏病,最常见于老年人。DHF的最佳管理尚未明确,尽管目前正在进行一些药物试验。许多研究表明,运动训练可使典型心力衰竭患者的功能能力提高15-20%。然而,迄今为止,培训尚未在DHF中试行。在这项多中心、多学科研究中,我们将研究训练组和对照组,以确定运动能力和DHF症状是否对运动训练有反应。这项工作将教会我们最佳的运动处方,在训练的持续时间和性质,以及运动训练的安全性和有效性方面。通过使用一些敏感的心脏和血管功能的测量(在这方面,我们的小组有特殊的专业知识),我们将确定运动训练是否通过改善血管功能和心肌特性发挥其作用。如果成功,本研究的临床意义是:1。通过运动训练改善DHF 2患者的功能和症状. DHF 3将确定有氧和力量训练的优点。血管功能异常将被确定为DHF的主要和可逆贡献者
英文摘要
Heart failure is modern epidemic which presents a significant public health burden, due to a high mortality, frequent hospital admissions and impaired functional capacity. Although the typical heart failure patient presents with a reduced contractile function, many patients have typical heart failure symptoms but with normal contraction. The problem in these patients seems to relate to the heart's ability to fill with blood, and this entity is known as diastolic heart failure (DHF). This syndrome is most frequently due to ischemic or hypertensive heart disease, and most commonly occurs in the elderly. The optimal management of DHF is not well defined, although some drug trials are currently in progress. A number of studies have shown exercise training to improve functional capacity by 15-20% in typical heart failure. However, training has not so far been trialled in DHF. In this multicenter, multi-disciplinary study, we will study a training and control group to determine whether exercise capacity and DHF symptoms are responsive to exercise training. This work will teach us about the optimum exercise prescription, in terms of the duration and nature of training, as well as the safety and effectiveness of exercise training. By using a number of sensitive measurements of heart and vessel function (in which our group has special expertise), we will identify whether exercise training exerts its effect through improvement in vascular function and myocardial properties. If successful, the clinical implications of this study are that; 1. Exercise training will be adopted to improve functional capacity and symptoms of DHF 2. The merits of aerobic and strength training will be identified in DHF 3. Abnormal blood vessel function will be identified as a major and reversible contributor to DHF
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Multi-Centre Double-Blind Randomised Placebo-Controlled Trial of Oral Anticoagulation in Systemic Sclerosis-Related Pulmonary Arterial Hypertension
  • 批准号:
    nhmrc : 1062638
  • 项目类别:
    Project Grants
  • 资助金额:
    $79.38万
  • 财政年份:
    2014
  • 负责人:
    A/Pr David Prior
  • 依托单位:
A Clinical Trial of Anticoagulation in Scleroderma Heart-Lung Disease
  • 批准号:
    nhmrc : GNT1062638
  • 项目类别:
    Project Grants
  • 资助金额:
    $113.96万
  • 财政年份:
    2014
  • 负责人:
    A/Pr David Prior
  • 依托单位:
Screening Evaluation of the Evolution of New Heart Failure Extension Study
NT-proBNP and the identification and treatment of structural heart disease and heart failure in high-risk individuals
国内基金
海外基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI Z
  • 依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
  • 批准号:
    W2433169
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI ZHANG
  • 依托单位:
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
  • 批准号:
    82371255
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    曹立
  • 依托单位:
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
  • 批准号:
    82370979
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张善勇
  • 依托单位: